| Recruiting | Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS NCT07461545 | Northern Jiangsu People's Hospital | N/A |
| Recruiting | Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD NCT07461532 | Northern Jiangsu People's Hospital | N/A |
| Recruiting | Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection NCT07462091 | Northern Jiangsu People's Hospital | N/A |
| Not Yet Recruiting | Carvedilol and Alverine in Portal Hypertension NCT06696248 | Shanghai Changzheng Hospital | Phase 2 / Phase 3 |
| Not Yet Recruiting | The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension NCT06473493 | Shanghai Changzheng Hospital | Phase 2 / Phase 3 |
| Not Yet Recruiting | The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis NCT06470386 | Shanghai Changzheng Hospital | Phase 2 / Phase 3 |
| Active Not Recruiting | Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal Bleeding NCT06437964 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Terminated | A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vei NCT06082843 | Boehringer Ingelheim | Phase 2 |
| Terminated | A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis NCT05282121 | Boehringer Ingelheim | Phase 2 |
| Terminated | A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pres NCT05161481 | Boehringer Ingelheim | Phase 2 |
| Completed | Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection NCT05304455 | Northern Jiangsu People's Hospital | N/A |
| Recruiting | SHAPE of Portal Hypertension in Children NCT04720456 | Thomas Jefferson University | Phase 2 |
| Unknown | Multiparametric Cardio-hepatic MRI in Patients With Noncirrhotic Portal Hypertension NCT05041452 | University Hospital, Bonn | — |
| Completed | Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements NCT04668664 | Cook Research Incorporated | — |
| Completed | Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAW NCT04645550 | Northern Jiangsu People's Hospital | Phase 4 |
| Active Not Recruiting | Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Co NCT04315571 | University of California, Los Angeles | N/A |
| Completed | TIPS Plus Transvenous Obliteration for Gastric Varices NCT04044248 | University of Illinois at Chicago | — |
| Completed | MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802) NCT03766880 | Nanfang Hospital, Southern Medical University | N/A |
| Unknown | Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802) NCT03713606 | Nanfang Hospital, Southern Medical University | — |
| Completed | Outcome After TIPS NCT03459378 | Medical University of Graz | — |
| Unknown | Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM) NCT03470389 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | N/A |
| Completed | Serelaxin To Lower Portal Pressure NCT02669875 | University of Edinburgh | Phase 2 |
| Withdrawn | Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702) NCT03177499 | Nanfang Hospital, Southern Medical University | N/A |
| Completed | Radiomics Signature of Hepatic Venous Pressure Gradient (rHVPG) With CT Angiography (CHESS1701) NCT03138915 | Nanfang Hospital, Southern Medical University | N/A |
| Completed | PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors) NCT03175731 | Yanjing Gao | Phase 4 |
| Unknown | Spleen-ARFI-assisted-Portal-Hypertension-Evaluation-Study (SAPHES) NCT03315767 | University of Ulm | N/A |
| Completed | Virtual Hepatic Venous Pressure Gradient (vHVPG) With CT Angiography (CHESS1601) NCT02842697 | Nanfang Hospital, Southern Medical University | N/A |
| Unknown | Evaluation of Gastroesophageal Varices by Transnasal Endoscopy. NCT02767206 | Federal University of Minas Gerais | — |
| Completed | Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resul NCT02462967 | Galectin Therapeutics Inc. | Phase 2 |
| Unknown | Follow-up Study of Complications of Acute Pancreatitis NCT02305914 | The First Affiliated Hospital of Nanchang University | — |
| Unknown | Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal Varices NCT02256046 | Tanta University | N/A |
| Completed | Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With C NCT01095185 | Juan A. Arnaiz | Phase 3 |
| Unknown | Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Trans NCT02504034 | Sun Yat-sen University | N/A |
| Unknown | Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptom NCT02505152 | Sun Yat-sen University | N/A |
| Unknown | Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy NCT01097811 | UPECLIN HC FM Botucatu Unesp | N/A |